Physician profile
Ziqing Wang
NPI 1649425158
$8,193.12
in general payments reported to CMS, 2019-2025
13 companies · $874 in 2025
The $874 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $64.52 · 2021: $3,864 · 2022: $536 · 2023: $192 · 2024: $1,834 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,860 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,860.04 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,266.40 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Davol INC. | $3,019.13 | 2021 | |
| Cook Medical LLC | $1,141.09 | 2019-2025 | Zenith Alpha, Zenith Spiral-Z, Zilver Ptx |
| Bolton Medical INC | $248.72 | 2021-2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Medtronic, INC. | $110.00 | 2021-2023 | Surgipro Ll |
| Abbott Laboratories | $101.36 | 2024 | Eterna |
| Endologix LLC | $100.82 | 2019-2021 | |
| Lemaitre Vascular, INC. | $56.17 | 2023-2024 | Artegraft Vascular Graft, Restoreflow |
| Terumo Medical Corporation | $44.81 | 2019 | |
| Boston Scientific Corporation | $39.73 | 2025 | Enroute Transcarotid Neuroprotection System |
| Silk Road Medical, INC. | $30.18 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Artivion, INC. | $19.55 | 2024 | Vascular |
| Tactile Systems Technology INC | $15.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziqing Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.